Third Harmonic Bio Inc. filings document the company's regulatory transition following stockholder approval of its Plan of Liquidation and Dissolution. Recent records include Form 8-K disclosures on the approved dissolution plan, material modifications to common-stock rights, Nasdaq delisting steps, and related governance and capital-structure matters.
The filing record also includes Form 25 for voluntary withdrawal of the common stock from Nasdaq listing and registration under Section 12(b) of the Exchange Act, and Form 15 for termination of registration under Section 12(g) or suspension of Exchange Act reporting obligations.
Third Harmonic Bio, Inc. (THRD) filed Post-Effective Amendment No. 1 to four Form S-8 registration statements in order to deregister all unsold shares that were previously registered under its 2019 Stock Incentive Plan, 2022 Equity Incentive Plan and 2022 Employee Stock Purchase Plan. The affected filings (Nos. 333-267445, 333-270935, 333-278232 and 333-286189) had collectively covered ≈15.4 million shares of common stock.
The action stems from the company’s Plan of Dissolution, approved by the board on 10-Apr-2025 and by shareholders on 5-Jun-2025. A Certificate of Dissolution became effective 31-Jul-2025, officially placing the company in liquidation and terminating all offerings under the Securities Act. Pursuant to Rule 478, only CFO & Business Officer Christopher Murphy signed the amendments.
No operating or financial data are provided; the filing strictly notifies investors that equity incentive and ESPP shares will no longer be issued.
Third Harmonic Bio, Inc. (THRD) has filed Post-Effective Amendment No. 1 to four previously effective Form S-8 registration statements (File Nos. 333-267445, 333-270935, 333-278232 and 333-286189). The amendments deregister all shares of common stock that remain unsold under the company’s 2019 Stock Incentive Plan, 2022 Equity Incentive Plan and 2022 Employee Stock Purchase Plan.
The action follows the company’s wind-down: the board adopted a Plan of Dissolution on Apr 10 2025, shareholders approved it on Jun 5 2025, and a Certificate of Dissolution was filed on Jul 31 2025, becoming effective immediately. In line with the plan, THRD has terminated all securities offerings and is amending the S-8 filings to remove any unsold securities from registration. The amendment was signed by Chief Financial & Business Officer Christopher Murphy; no additional signatures are required under Rule 478.